The integrative bioinformatic analysis deciphers the predicted molecular target gene and pathway from curcumin derivative CCA-1.1 against triple-negative breast cancer (TNBC)

Overview of attention for article published in Journal of the Egyptian National Cancer Institute, August 2021

Altmetric Badge

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 16 Mendeley

Summary Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology

Article in Aging (February 2024)

Chemoprevention curcumin analog 1.1 promotes metaphase arrest and enhances intracellular reactive oxygen species levels on TNBC MDA-MB-231 and HER2-positive HCC1954 cells

Article in Research in Pharmaceutical Sciences (June 2023)

Demystifying the Role of Prognostic Biomarkers in Breast Cancer through Integrated Transcriptome and Pathway Enrichment Analyses

Article in Diagnostics (March 2023)